Financial Highlights for the Second Quarter Ended
- Revenues for the second quarter ended
June 30, 2026 increased by 29.8% year over year, reaching a second quarter record-breaking$782.4 million , compared to$602.7 million in the same period last year. - Operating income for the second quarter ended
June 30, 2026 increased by 41.3% year over year, reaching$71.6 million compared to$50.7 million in the same period last year. - Net income from continued operations attributable to Formula’s shareholders for the second quarter ended
June 30, 2026 , increased by approximately 163.7% year over year, reaching$23.3 million , or$1.47 per fully diluted share, compared to$8.8 million , or$0.56 per fully diluted share, in the same period last year. - Net income attributable to Formula's shareholders for the second quarter ended
June 30, 2026 increased by approximately 54.6% year over year, reaching$23.3 million , or$1.47 per fully diluted share, compared to$15.1 million , or$0.95 per fully diluted share, in the same period last year.
Financial Highlights for First Half Ended
- Revenues for the six-month period ended
June 30, 2026 increased by 24.4% year over year, reaching a first half record-breaking$1.52 billion , compared to$1.22 billion in the same period last year. - Operating income for the six-month period ended
June 30, 2026 increased by 53.3% year over year, reaching$153.7 million compared to$100.2 million in the same period last year. Operating income for the first half of 2026 included a capital gain of$16.6 million resulting from exercise of employee stock-based compensation and a secondary private placement transaction completed by our affiliate, TSG IT Advanced Systems Ltd. ("TSG"), inJanuary 2026 . OnJanuary 13, 2026 , TSG's Board of Directors approved a capital raise through a private placement to institutional investors, pursuant to which TSG raised approximatelyNIS 192 million (approximately$58.9 million ) through the issuance of 320,374 ordinary shares at a price ofNIS 600 per share, together with 128,150 non-tradable warrants (allocated at no additional consideration at a ratio of 0.4 warrant per share), each exercisable for one ordinary share at an exercise price ofNIS 720 per share throughJuly 22, 2027 . The allocated shares and warrants represent approximately 9.23% of TSG's fully diluted share capital. As a result of this transaction and the exercise of TSG’s employee stock-based compensation, during the six-month period endedJune 30, 2026 Formula's ownership interest in TSG was diluted from 37.33% to 32.87%, resulting with a$16.6 million capital gain. Excluding this capital gain, operating income would have increased by 36.7% year over year, to$137.0 million . - Net income from continued operations attributable to Formula’s shareholders for the six-month period ended
June 30, 2026 increased by approximately 186.4% year over year, reaching$58.9 million , or$3.72 per fully diluted share, compared to$20.6 million , or$1.31 per fully diluted share, in the same period last year. Excluding the impact of the capital gain resulting from TSG’s secondary private placement transaction and the exercise of TSG’s employee stock-based compensation, net income from continued operations attributable to Formula’s shareholders would have increased by 105.5% year over year, to$42.3 million . - Net income attributable to Formula's shareholders for the six-month period ended
June 30, 2026 increased by approximately 71.4% year over year, reaching$58.9 million , or$3.72 per fully diluted share, compared to$34.4 million , or$2.20 per fully diluted share, in the same period last year. Excluding the impact of the capital gain resulting from TSG’s secondary private placement transaction and the exercise of TSG’s employee stock-based compensation, net income attributable to Formula’s shareholders would have increased by 23.0% year over year, to$42.3 million . - As of
June 30, 2026 , Formula held 47.68%, 18.68%, 69.09%, 32.87%, 90.09%, 80%, 100%, 100%, 51% and 100% of the outstanding ordinary shares of Matrix IT Ltd.,SI Swan UK Topco Limited ., Michpal Technologies Ltd., TSG IT Advanced Systems Ltd.,Insync Staffing, Inc. ,Ofek Aerial Photography Ltd. ,ZAP Group Ltd. , Shamrad Electronic (1997) Ltd.,Hashahar Telecom And Electricity Ltd. , andFormula Infrastructure Ltd. , respectively. - Consolidated cash and cash equivalents and short-term bank deposits totaled approximately
$864 .5 million as ofJune 30, 2026 , compared to$1 ,280 million as ofDecember 31, 2025 . - Total equity as of
June 30, 2026 was$1.66 billion (representing 47.2% of the total consolidated statements of financial position), compared to$1.78 billion (representing 49.6% of the total consolidated statements of financial position) as ofDecember 31, 2025 . - The above comparative figures for the second quarter and first half ended
June 30, 2025 reflect the reclassification of the results of Sapiens (of which Formula sold its controlling interest inDecember 2025 ), as discontinued operations, in accordance with IFRS 5. Similarly, the Company’s record-breaking consolidated results for the second quarter and first half endedJune 30, 2026 (as described above) are relative to the Company’s historical consolidated results in prior years that exclude Sapiens.
Debentures Covenants
As of
Covenant 1
- Target equity attributable to Formula’s shareholders (excluding non-controlling interests): above
$325 million . - Actual equity attributable to Formula’s shareholders as of
June 30, 2026 was$1.21 billion .
Covenant 2
- Target ratio of net financial indebtedness to net capitalization (in each case, as defined under the indenture for Formula’s Series C and D Secured Debentures): below 65%.
- Actual ratio of net financial indebtedness to net capitalization, as of
June 30, 2026 was (27.08%).
Covenant 3
- Target ratio of net financial indebtedness to EBITDA (based on the accumulated calculation for the four most recent quarters): below 5.
- Actual ratio of net financial indebtedness to EBITDA as of
June 30, 2026 was (2.07).
Declaration of Dividend
- Based on the Company’s strong cash position, primarily resulting from the net proceeds received in connection with Advent’s acquisition of Sapiens in
December 2025 , the Company’s board of directors approved the distribution of a cash dividend in an amount of$1.63 per share and in an aggregate amount of approximately$25.0 million . In reaching its decision to declare the dividend, the Board of Directors evaluated such factors as the current and foreseeable liquidity and capital needs of Formula and felt comfortable declaring the dividend and rewarding our longstanding shareholder. - The dividend will be paid on
October 6, 2026 to all of the Company’s shareholders of record at the close of trading on the Nasdaq Global Select Market (or the Tel-Aviv Stock Exchange, as appropriate) onSeptember 22, 2026 . The dividend will be paid inU.S dollars both with respect to the Company's ordinary shares traded on the Tel Aviv Stock Exchange and its American Depositary Receipts traded on the Nasdaq Global Select Market. - In accordance with Israeli tax law, the dividend is subject to withholding tax at source at the rate of 30% (if the recipient of the dividend is at the time of distribution or was at any time during the preceding 12-month period the holder of 10% or more of the Company's share capital) or 25% (for all other dividend recipients) of the dividend amount payable to each shareholder of record, subject to applicable exemptions.
Comments of Management
Commenting on the results,
“Matrix reported its second quarter and first half record-breaking results recorded across all its key financial indices: revenues, gross profit, operating income, net income and EBITDA. Matrix revenues for the second quarter grew by 6.3% year over year, when measured based on New Israeli Shekel, reaching an all-time second quarter high of
“Michpal Technologies opened 2026 with a strong first half, reflecting continued growth across all financial metrics and demonstrating its ability to leverage synergies and expand revenues and profits across it two business segments. With a solid cash position of approximately
“TSG concluded the second quarter of 2026 with record-breaking results, demonstrating significant growth in revenue and profits. Revenues for the second quarter increased by approximately 22% year over year to a second quarter record-breaking
Stand-Alone Financial Measures
This press release presents, further below, certain stand-alone financial measures to reflect Formula’s stand-alone financial position in reference to its assets and liabilities as the parent company of its group of companies. These financial measures are prepared consistently with the accounting principles applied in the consolidated financial statements of the group. Such measures include investments in subsidiaries and a jointly controlled entity measured at cost adjusted by Formula’s share in the investees’ accumulated undistributed earnings and other comprehensive income or loss.
Formula believes that these financial measures provide useful information to management and investors regarding Formula’s stand-alone financial position. Formula’s management uses these measures to compare the Company’s performance in the current period to that of prior periods for trend analysis. These measures are also used in financial reports prepared for management and in quarterly financial reports presented to the Company’s board of directors. The Company believes that the use of these stand-alone financial measures provides an additional tool for investors to use in evaluating Formula’s financial position.
Management of the Company does not consider these stand-alone measures in isolation or as an alternative to financial measures determined in accordance with IFRS.
About Formula
Formula Systems (1985) Ltd., whose ordinary shares are traded on the Tel-Aviv Stock Exchange and ADSs are traded on the Nasdaq Global Select Market, is a global information technology holding company engaged, through its subsidiaries and affiliates, in providing software consulting services and computer-based business solutions and developing proprietary software products.
For more information, visit www.formulasystems.com.
Press Contact:
Formula Systems (1985) Ltd.
+972-3-5389305
ir@formula.co.il
Forward Looking Statements
Certain matters discussed in this press release that are incorporated herein and therein by reference are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, that are based on Formula’s (“we,” “us” or “our”) beliefs, assumptions and expectations, as well as information currently available to us. Such forward-looking statements may be identified by the use of the words “anticipate,” “believe,” “estimate,” “expect,” “may,” “will,” “plan” and similar expressions. Such statements reflect our current views with respect to future events and are subject to certain risks and uncertainties. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to: adverse macro-economic trends and their duration, including persistent inflation, relatively high interest rates, and supply chain delays, which trends may last for a significant period and materially adversely affect our results of operations; the degree of our success in our plans to leverage our global footprint to grow our sales; the degree of our success in integrating the companies that we have acquired through the implementation of our M&A growth strategy; the degree of our success in developing and deploying new technologies for software solutions that address the updated needs of our customers and serve as the basis for our revenues; the lengthy development cycles for our solutions, which may frustrate our ability to realize revenues and/or profits from our potential new solutions; our lengthy and complex sales cycles, which do not always result in the realization of revenues; the degree of our success in retaining our existing customers or competing effectively for greater market share; difficulties in successfully planning and managing changes in the size of our operations; the frequency of the long-term, large, complex projects that we perform that involve complex estimates of project costs and profit margins, which sometimes change mid-stream; the challenges and potential liability that heightened privacy laws and regulations pose to our business; occasional disputes with clients, which may adversely impact our results of operations and our reputation; various intellectual property issues related to our business; potential unanticipated product vulnerabilities or cybersecurity breaches of our or our customers’ systems particularly in the current hybrid office/work-from-home environment; risks related to industries, such as the insurance, healthcare, defense and telecom industries, in which certain of our clients operate; risks posed by our global sales and operations, such as changes in regulatory requirements, supply chain disruptions, geopolitical factors, wide-spread viruses and epidemics or fluctuations in currency exchange rates; and risks related to our and our subsidiaries’ principal location in Israel.
While we believe such forward-looking statements are based on reasonable assumptions, should one or more of the underlying assumptions prove incorrect, or these risks or uncertainties materialize, our actual results may differ materially from those expressed or implied by the forward-looking statements. Please read the risks discussed under the heading “Item 3.D Risk Factors” in our most recent Annual Report on Form 20-F for the year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission on May 13, 2026, in order to review conditions that we believe could cause actual results to differ materially from those contemplated by the forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance, events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we do not undertake to update publicly any forward-looking statements for any reason, or to conform those statements to actual results or to changes in our expectations.
| CONSOLIDATED CONDENSED STATEMENTS OF PROFIT OR LOSS | |||||||||
| Three months ended | Six months ended | ||||||||
| 2026 | 2025 (*) | 2026 | 2025 (*) | ||||||
| Unaudited | Unaudited | ||||||||
| Revenues | 782,439 | 602,727 | 1,520,724 | 1,222,110 | |||||
| Cost of revenues | 624,009 | 479,613 | 1,216,258 | 978,767 | |||||
| Gross profit | 158,430 | 123,114 | 304,466 | 243,343 | |||||
| Research and development costs, net | 5,754 | 4,989 | 10,923 | 9,800 | |||||
| Selling, marketing and general and administrative expenses | 80,879 | 67,419 | 156,526 | 133,313 | |||||
| Other income (expenses), net | (148) | - | 16,637 | - | |||||
| Operating income | 71,649 | 50,706 | 153,654 | 100,230 | |||||
| Financial expenses, net | 5,630 | 11,105 | 9,800 | 17,599 | |||||
| Income before taxes on income | 66,019 | 39,601 | 143,854 | 82,631 | |||||
| Taxes on income | 14,064 | 10,841 | 29,441 | 21,810 | |||||
| Income after taxes | 51,955 | 28,760 | 114,413 | 60,821 | |||||
| Share of profit (loss) of companies accounted for at equity, net | (385) | 211 | (88) | 1,039 | |||||
| Net income from continued operations | 51,570 | 28,971 | 114,325 | 61,860 | |||||
| Net income from discontinued operations | - | 14,475 | - | 31,968 | |||||
| Net income | 51,570 | 43,446 | 114,325 | 93,828 | |||||
| Net income attributable to non-controlling interests from continued operations | 28,301 | 20,148 | 55,417 | 41,288 | |||||
| Net income attributable to non-controlling intersts from discontinued operations | - | 8,245 | - | 18,171 | |||||
| Net income attributable to non-controlling interest | 28,301 | 28,393 | 55,417 | 59,459 | |||||
| Net income attributable to Formula's shareholders from continued operations | 23,269 | 8,823 | 58,908 | 20,572 | |||||
| Net income attributable to Formula's shareholders from discontinued operations | - | 6,230 | - | 13,797 | |||||
| Net income attributable to Formula's shareholders | 23,269 | 15,053 | 58,908 | 34,369 | |||||
| Earnings per share: | |||||||||
| From continued operations (basic) | 1.52 | 0.58 | 3.85 | 1.35 | |||||
| From discontinued operations (basic) | - | 0.40 | - | 0.91 | |||||
| Earnings per share (basic) | 1.52 | 0.98 | 3.85 | 2.26 | |||||
| From continued operations (diluted) | 1.47 | 0.56 | 3.72 | 1.31 | |||||
| From discontinued operations (diluted) | - | 0.39 | - | 0.89 | |||||
| Earnings per share (diluted) | 1.47 | 0.95 | 3.72 | 2.20 | |||||
| Number of shares used in computing earnings per share (basic) | 15,317,817 | 15,308,389 | 15,317,442 | 15,308,014 | |||||
| Number of shares used in computing earnings per share (diluted) | 15,839,127 | 15,758,290 | 15,839,557 | 15,741,968 | |||||
| (*) Following the completion of the acquisition of | |||||||||
| figures for the second quarter and first half of 2025 have been reclassified to present the results of Sapiens as discontinued operations. | |||||||||
| CONSOLIDATED STATEMENTS OF FINANCIAL POSITION | ||||
| 2026 | 2025 | |||
| (Unaudited) | ||||
| ASSETS | ||||
| CURRENT ASSETS: | ||||
| Cash and cash equivalents | 863,790 | 1,280,121 | ||
| Short-term deposits | 360 | 372 | ||
| Marketable securities | 390 | - | ||
| Trade receivables, net | 947,333 | 774,471 | ||
| Prepaid expenses and other accounts receivable | 104,179 | 80,604 | ||
| Inventories | 51,786 | 30,249 | ||
| Total current assets | 1,967,838 | 2,165,817 | ||
| NON-CURRENT ASSETS: | ||||
| Financial assets measured at fair value through profit or loss | 306,135 | 304,549 | ||
| Long-term investments and receivables | 52,996 | 50,126 | ||
| Deferred taxes | 29,074 | 26,915 | ||
| Investments in companies accounted for at equity | 65,121 | 48,908 | ||
| Property, plants and equipment, net | 59,456 | 47,614 | ||
| Right-of-use assets | 154,254 | 145,462 | ||
| Intangible assets, net and goodwill | 871,106 | 793,864 | ||
| Total non-current assets | 1,538,142 | 1,417,438 | ||
| Total assets | 3,505,980 | 3,583,255 | ||
| LIABILITIES AND EQUITY | ||||
| CURRENT LIABILITIES: | ||||
| Loans from banks and others | 207,044 | 177,899 | ||
| Debentures | 82,521 | 76,696 | ||
| Current maturities of lease liabilities | 45,716 | 42,899 | ||
| Trade payables | 371,658 | 368,319 | ||
| Deferred revenues | 197,961 | 157,545 | ||
| Employees and payroll accrual | 242,641 | 235,705 | ||
| Other accounts payable | 82,522 | 195,817 | ||
| Dividend payable | - | 7,886 | ||
| Liabilities in respect of business combinations | 17,714 | 6,359 | ||
| Put options of non-controlling interests | 85,630 | 61,206 | ||
| Total current liabilities | 1,333,407 | 1,330,331 | ||
| LONG-TERM LIABILITIES: | ||||
| Loans from banks and others | 22,014 | 68,309 | ||
| Debentures | 115,888 | 118,656 | ||
| Convertible debentures | 84,133 | - | ||
| Lease liabilities | 113,280 | 107,805 | ||
| Other long-term liabilities | 1,459 | 54 | ||
| Deferred taxes | 87,871 | 83,426 | ||
| Deferred revenues | 15,323 | 16,457 | ||
| Liabilities in respect of business combinations | 4,248 | 13,291 | ||
| Put options of non-controlling interests | 66,828 | 61,577 | ||
| Employee benefit liabilities | 5,480 | 5,547 | ||
| Total long-term liabilities | 516,524 | 475,122 | ||
| EQUITY | ||||
| Total equity attributable to | 1,206,092 | 1,353,263 | ||
| Non-controlling interests | 449,957 | 424,539 | ||
| Total equity | 1,656,049 | 1,777,802 | ||
| Total liabilities and equity | 3,505,980 | 3,583,255 | ||
| STAND-ALONE STATEMENTS OF FINANCIAL POSITION | |||||
| 2026 | 2025 | ||||
| (Unaudited) | (Unaudited) | ||||
| ASSETS | |||||
| CURRENT ASSETS: | |||||
| Cash and cash equivalents | 493,594 | 793,131 | |||
| Dividend receivable | 17,583 | 448 | |||
| Other accounts receivable and prepaid expenses | 5,742 | 5,527 | |||
| Total current assets | 516,919 | 799,106 | |||
| NON-CURRENT ASSETS: | |||||
| Investment in subsidiaries and a jointly controlled entity (*) | |||||
| Matrix IT Ltd. | 327,363 | 183,214 | |||
| - | 132,183 | ||||
| TSG IT Advanced Systems Ltd. | 54,827 | 33,882 | |||
| 108,255 | 108,099 | ||||
| 50,041 | 48,154 | ||||
| Other | 79,618 | 50,428 | |||
| Total investment in subsidiaries and a jointly controlled entity | 620,104 | 555,960 | |||
| Financial assets measured at fair value through profit or loss | 302,149 | 300,000 | |||
| Other investments and Long term receivables | 21,990 | 23,904 | |||
| Property, plants and equipment, net | 31 | 13 | |||
| Total non-current assets | 944,274 | 879,877 | |||
| Total assets | 1,461,193 | 1,678,983 | |||
| LIABILITIES AND EQUITY | |||||
| CURRENT LIABILITIES: | |||||
| Loans from banks and others | 52,046 | 15,158 | |||
| Debentures | 56,104 | 52,350 | |||
| Trade payables | 1,380 | 963 | |||
| Other accounts payable | 46,480 | 152,634 | |||
| Put options of non-controlling interests | 2,618 | 992 | |||
| Dividends payable | - | 7,883 | |||
| Total current liabilities | 158,628 | 229,980 | |||
| LONG-TERM LIABILITIES: | |||||
| Loans from banks and others | - | 871 | |||
| Debentures | 49,599 | 46,204 | |||
| Deferred taxes Liability | 46,874 | 48,665 | |||
| Total long-term liabilities | 96,473 | 95,740 | |||
| EQUITY | 1,206,092 | 1,353,263 | |||
| TOTAL LIABILITIES AND EQUITY | 1,461,193 | 1,678,983 | |||
| (*) | The investments' carrying amounts are measured consistent with the accounting principles applied in the consolidated financial statements of the Group and representing the investments’ cost adjusted by Formula’s share in the investees’ accumulated undistributed earnings and other comprehensive income or loss. | ||||
Source: 